Infectious Diseases (except HIV/AIDS)

  1. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis

    1. Md Mostaured Ali Khan
    2. Md Nuruzzaman Khan
    3. Md Golam Mustagir
    4. Juwel Rana
    5. Md Saiful Islam
    6. Md Iqbal Kabir

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens

    1. Colin R. Zamecnik
    2. Jayant V. Rajan
    3. Kevin A. Yamauchi
    4. Sabrina A. Mann
    5. Rita P. Loudermilk
    6. Gavin M. Sowa
    7. Kelsey C. Zorn
    8. Bonny D. Alvarenga
    9. Christian Gaebler
    10. Marina Caskey
    11. Mars Stone
    12. Philip J. Norris
    13. Wei Gu
    14. Charles Y. Chiu
    15. Dianna Ng
    16. James R. Byrnes
    17. Xin X. Zhou
    18. James A. Wells
    19. Davide F. Robbiani
    20. Michel C. Nussenzweig
    21. Joseph L. DeRisi
    22. Michael R. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E

    1. Luisa A. Ikner
    2. Jason R. Torrey
    3. Patricia M. Gundy
    4. Charles P. Gerba

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Modelling the Evolution of COVID-19 in High-Incidence European Countries and Regions: Estimated Number of Infections and Impact of Past and Future Intervention Measures

    1. Juan Fernández-Recio

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection

    1. Xin Hou
    2. Xiaomei Zhang
    3. Xian Wu
    4. Minya Lu
    5. Dan Wang
    6. Meng Xu
    7. Hongye Wang
    8. Te Liang
    9. Jiayu Dai
    10. Hu Duan
    11. Yingchun Xu
    12. Xiaobo Yu
    13. Yongzhe Li

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A novel box for aerosol and droplet guarding and evacuation in respiratory infection (BADGER) for COVID-19 and future outbreaks

    1. Hau D. Le
    2. Gordon A. Novak
    3. Kevin C. Janek
    4. Jesse Wang
    5. Khang N. Huynh
    6. Chris Myer
    7. Adam Weinstein
    8. Erick L. Oberstar
    9. Jim Rasmussen
    10. Timothy H. Bertram

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients

    1. Huarong Chen
    2. Weixin Liu
    3. Yifei Wang
    4. Dabin Liu
    5. Liuyang Zhao
    6. Jun Yu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Association of Vitamin D Deficiency and Treatment with COVID-19 Incidence

    1. David O. Meltzer
    2. Thomas J. Best
    3. Hui Zhang
    4. Tamara Vokes
    5. Vineet Arora
    6. Julian Solway

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab

    1. Adrián Sánchez-Montalvá
    2. Júlia Sellarés-Nadal
    3. Juan Espinosa-Pereiro
    4. Nuria Fernández-Hidalgo
    5. Santiago Pérez-Hoyos
    6. Fernando Salvador
    7. Xavier Durà
    8. Marta Miarons
    9. Andrés Antón
    10. Simeón Eremiev-Eremiev
    11. Abiu Sempere-González
    12. Arnau Monforte-Pallarés
    13. Pau Bosch-Nicolau
    14. Salvador Augustin
    15. Júlia Sampol
    16. Alfredo Guillén-del-Castillo
    17. Benito Almirante

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009

    1. Amanda M. Rojek
    2. Genevieve E. Martin
    3. Peter W. Horby

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 82 of 716 Next